UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2551
PUT
Linde
LIN
$239B
| $22.6M | ﹤0.01% |
43,600
-46,687
| -52% | -$23.6M |
2018 Q4
30 quarters
|
|
2552
Guggenheim Strategic Opportunities Fund
GOF
$2B
| $22.6M | ﹤0.01% |
2,071,032
+153,820
| +8% | +$1.72M |
2014 Q4
46 quarters
|
|
2553
Par Pacific Holdings
PARR
$3.44B
| $22.6M | ﹤0.01% |
402,984
-2,755
| -0.7% | -$164K |
2014 Q4
46 quarters
|
|
2554
PUT
Pfizer
PFE
$170B
| $22.6M | ﹤0.01% |
938,331
-69,000
| -7% | -$1.8M |
2014 Q4
46 quarters
|
|
2555
Sharplink Inc
SBET
$1.39B
| $22.6M | ﹤0.01% |
4,703,344
-128,774
| -3% | -$823K |
2024 Q1
9 quarters
|
|
2556
First Trust Financials AlphaDEX Fund
FXO
$1.08B
| $22.5M | ﹤0.01% |
360,777
-44,820
| -11% | -$2.67M |
2014 Q4
46 quarters
|
|
2557
Kayne Anderson Energy Infrastructure Fund
KYN
$2.22B
| $22.5M | ﹤0.01% |
1,627,868
+82,404
| +5% | +$1.14M |
2014 Q4
46 quarters
|
|
2558
Global E Online
GLBE
$7.28B
| $22.5M | ﹤0.01% |
648,152
-608,406
| -48% | -$19.2M |
2021 Q2
20 quarters
|
|
2559
Louisiana-Pacific
LPX
$5.38B
| $22.5M | ﹤0.01% |
285,981
-29,319
| -9% | -$2.17M |
2014 Q4
46 quarters
|
|
2560
CALL
Invesco S&P 500 Low Volatility ETF
SPLV
$7.61B
| $22.5M | ﹤0.01% |
+300,000
| New | +$22.1M |
2026 Q2
0 quarters
|
|
|
2561
PUT
Invesco S&P 500 Low Volatility ETF
SPLV
$7.61B
| $22.5M | ﹤0.01% |
+300,000
| New | +$22.1M |
2026 Q2
0 quarters
|
|
2562
Eldorado Gold
EGO
$9.05B
| $22.4M | ﹤0.01% |
721,941
+428,713
| +146% | +$14M |
2014 Q4
46 quarters
|
|
2563
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.39B
| $22.4M | ﹤0.01% |
742,278
+14,484
| +2% | +$433K |
2014 Q4
46 quarters
|
|
2564
Digital Turbine
APPS
$1.18B
| $22.4M | ﹤0.01% |
1,733,765
+981,439
| +130% | +$5.87M |
2014 Q4
46 quarters
|
|
2565
GraniteShares 2x Long COIN Daily ETF
CONL
$321M
| $22.3M | ﹤0.01% |
5,234,082
+1,628,160
| +45% | +$11.6M |
2023 Q3
11 quarters
|
|
2566
Avalo Therapeutics
AVTX
$356M
| $22.3M | ﹤0.01% |
1,209,059
+67,079
| +6% | +$1.06M |
2023 Q4
10 quarters
|
|
2567
PUT
McDonald's
MCD
$197B
| $22.3M | ﹤0.01% |
82,613
-100,100
| -55% | -$28.7M |
2014 Q4
46 quarters
|
|
2568
VanEck CEF Muni Income ETF
XMPT
$205M
| $22.3M | ﹤0.01% |
999,336
-14,249
| -1% | -$311K |
2021 Q3
19 quarters
|
|
2569
Hudbay
HBM
$9.14B
| $22.3M | ﹤0.01% |
945,557
+134,950
| +17% | +$3.41M |
2014 Q4
46 quarters
|
|
2570
Nurix Therapeutics
NRIX
$1.62B
| $22.2M | ﹤0.01% |
917,117
-59,245
| -6% | -$1.01M |
2021 Q1
21 quarters
|
|
2571
PUT
Accenture
ACN
$162B
| $22.2M | ﹤0.01% |
178,091
+16,679
| +10% | +$2.9M |
2016 Q3
39 quarters
|
|
2572
Opendoor
OPEN
$1.74B
| $22.2M | ﹤0.01% |
4,795,931
-2,380,602
| -33% | -$11.4M |
2020 Q2
24 quarters
|
|
2573
iShares iBonds Dec 2032 Term Treasury ETF
IBTM
$621M
| $22.2M | ﹤0.01% |
976,161
-19,549
| -2% | -$445K |
2022 Q4
14 quarters
|
|
2574
PUT
Humana
HUM
$49.4B
| $22.1M | ﹤0.01% |
55,700
-4,400
| -7% | -$1.25M |
2021 Q4
18 quarters
|
|
2575
AppFolio
APPF
$8.27B
| $22.1M | ﹤0.01% |
137,692
+37,555
| +38% | +$6M |
2015 Q4
42 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.